News Conference News ISC 2026 OPTION: IV Tenecteplase Boosts Outcomes Late After Non-LVO Stroke Todd Neale February 11, 2026
News Daily News AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline Todd Neale January 29, 2026
News Daily News HOPE Supports IV Alteplase in Late Window After Acute Ischemic Stroke Todd Neale August 11, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2025 Caitlin E. Cox April 01, 2025
News Daily News RAISE: Reteplase May Be Another Option for Stroke Thrombolysis Todd Neale June 20, 2024
News Conference News ESOC 2024 TEMPO-2: Tenecteplase No Help in Mild Stroke With Proven Occlusion Todd Neale May 23, 2024
News Conference News ESOC 2024 More Trial Evidence Supports Tenecteplase for Acute Stroke Thrombolysis Todd Neale May 21, 2024
News Conference News ACC 2023 STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients L.A. McKeown March 10, 2023
News Conference News ISC 2023 Tenecteplase Matches Up Well With Alteplase in Acute Stroke: TRACE-2 Todd Neale February 14, 2023
News Conference News ISC 2022 Tenecteplase Feasible Up to 24 Hours After Stroke Todd Neale February 15, 2022
News Conference News TCT 2021 No Harm From Thrombolytics in SCAD Patients With STEMI Michael O'Riordan October 13, 2021
News Daily News Switching to Tenecteplase for Stroke Thrombolysis May Boost Outcomes Todd Neale September 09, 2021
News Conference News ISC 2021 Is Tenecteplase Ready for Prime Time in Acute Stroke? Todd Neale March 19, 2021
News Daily News Antithrombotic Therapy for COVID-19: Challenges and Lessons for the Future L.A. McKeown March 17, 2021
News As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI Michael O'Riordan April 17, 2020
News Daily News Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences Todd Neale August 18, 2017